Drug intelligence / Profile preview

Sundance Sirolimus DCB

Development stage
Unknown
Lead developer
SurModics
Modality
Small Molecules
Administration
Intra-arterial
01

Overview

The Sundance Sirolimus DCB (Drug-Coated Balloon) is an investigational medical device developed by Surmodics, Inc. for the treatment of occlusive disease in the infrapopliteal (below-the-knee) arteries. The device utilizes a next-generation coating technology that combines microcrystalline sirolimus with a proprietary excipient to optimize drug transfer and maintain therapeutic levels in the arterial wall during and after balloon dilatation. Sirolimus, the active pharmaceutical ingredient, is a potent anti-proliferative and anti-inflammatory small molecule that inhibits the mechanistic target of rapamycin (mTOR), thereby preventing the cellular proliferation that leads to restenosis. The Sundance Sirolimus DCB is currently being evaluated in the SWING trial, a first-in-human feasibility study involving patients with stenotic or occluded lesions of the infrapopliteal arteries.

Brand names
Sundance Sirolimus DCB
Other names
Sundance DCBSurmodics Sirolimus DCB
02

Targets

FKBP1AMechanistic target of rapamycin complex 1

Beyond the preview

Go deeper on Sundance Sirolimus DCB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sundance Sirolimus DCB.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call